Amgen appoints former Yum! Brands CEO David W. Gibbs to its board, adding global leadership and consumer brand expertise.

AIG Hospitals and Boston Scientific launch a three-year partnership to train doctors in advanced endoscopy and minimally ...

C-CAMP-backed Tranalab joins Wellcome Leap’s Focused Antibiotics programme to develop targeted treatment for lower ...

Bayer secures China’s first global approval for Sunharbo, a Factor XIa inhibitor designed to reduce recurrent stroke risk.

The collaboration will introduce the FDA-cleared Onclarity Self-Collection Kit across clinical, health plan and consumer ...

Mankind Pharma reports a 39.2% rise in Q2 profit to ₹712 crore as revenue grows 17.3%, alongside approvals for subsidiary ...

Amaha nears a ₹100 crore fundraise to expand its mental healthcare network, strengthen clinical teams and invest in ...

PharmEasy highlights breast cancer awareness, regular screening, early detection and access to affordable cancer care.

AstraZeneca's experimental drug sone-ve doubled median overall survival to 10 months in a late-stage trial for advanced ...

Uganda orders 21-day quarantine for returning travellers from DR Congo and strengthens Ebola screening following cases in ...

Roche licenses’ ZW209 lung cancer therapy in a deal worth up to $813 million, including upfront and milestone payments.

WHO launches a traditional medicine working paper series, beginning with a review of cupping therapy training and practices.